MALIGNANT HEPATOBILIARY NEOPLASM

MALIGNANT HEPATOBILIARY NEOPLASM was reported 7 times

MALIGNANT HEPATOBILIARY NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
1 Nonergot Dopamine Agonist [EPC] 1 0.0001
2 Methylxanthine [EPC] 1 0.0000
3 Glycopeptide Antibacterial [EPC] 1 0.0000
4 Central Nervous System Stimulant [EPC] 1 0.0000
5 Thiazide Diuretic [EPC] 2 0.0000
6 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
7 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
8 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
9 Platelet Aggregation Inhibitor [EPC] 1 0.0000
10 Benzodiazepine [EPC] 1 0.0000
11 Corticosteroid [EPC] 1 0.0000